This pioneering study provides compelling evidence that the combination of NGR1 and SSB2 (NS) effectively mitigates inflammation and inhibits the activation of the PI3K/Akt/mTOR signaling pathway in atherosclerosis. This evidence concerns the gene AKT1 and atherosclerosis.